Human Flt3L Generates Dendritic Cells from Canine Peripheral Blood Precursors: Implications for a Dog Glioma Clinical Trial

Weidong Xiong, Marianela Candolfi, Chunyan Liu et al. · 2010

Read Human Flt3L Generates Dendritic Cells from Canine Peripheral Blood Precursors: Implications for a Dog Glioma Clinical Trial by Weidong Xiong, Marianela Candolfi, Chunyan Liu et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011074.txt.

Description

Weidong Xiong, Marianela Candolfi, Chunyan Liu and co-authors published this brain tumor therapy study in PLOS ONE in 2010. Glioblastoma is the commonest primary brain tumor in adults and one of the deadliest. The team is developing a gene therapy. It pairs an immune-stimulating cytokine, Flt3L, with a conditional cell-killing gene. They aim to test it in pet dogs with spontaneous tumors, as a bridge to human trials.

A key doubt was whether the human cytokine works on dog immune cells. Delivered by an adenovirus vector into dog blood cell cultures, human Flt3L generated dendritic cells closely matching those raised with dog immune factors in shape and surface markers. Xiong and colleagues clear a make-or-break checkpoint: the human ingredient can raise the canine immune instructors the therapy depends on, so a dog clinical trial can proceed.

Catalog record

CREATORWeidong Xiong, Marianela Candolfi, Chunyan Liu et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011074

Browse the full library · About the Tower of Babel